RESEARCH DEVELOPMENT FOUNDATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 83172
 
  
 
C07K PEPTIDES 7267
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 53114
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 19187
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1881
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13112
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1287
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 986
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5235

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0030,478 ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTSJun 30, 17Feb 01, 18[A61K, C12N]
2017/0296,646 ATTENUATED ZIKA VIRUS CONSTRUCTS AND USES THEREOFMar 28, 17Oct 19, 17[A61K, C12N, C07K]
2017/0233,444 RTEF-1 VARIANTS AND USES THEREOFMay 02, 17Aug 17, 17[A61K, C12N, C07K]
2017/0233,781 METHODS FOR GENERATING ENGINEERED ENZYMESOct 14, 15Aug 17, 17[C12Q, C12P, G01N, G06F]
2017/0204,168 IMMUNOREACTIVE PROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSISMar 27, 17Jul 20, 17[G01N, C07K]
2017/0166,628 VACCINES AND DIAGNOSTICS FOR THE EHRLICHIOSESFeb 23, 17Jun 15, 17[A61K, C07K]
2017/0151,245 METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES AND AMYLOID BETA AMYLOIDOSIS BY MODULATING CRF RECEPTOR SIGNALINGDec 12, 16Jun 01, 17[A61K, G01N, A01K]
2017/0067,079 METHODS AND COMPOSITIONS RELATING TO RESTRICTED EXPRESSION LENTIVIRAL VECTORS AND THEIR APPLICATIONSApr 19, 16Mar 09, 17[C12N, C07K]
2017/0037,091 STY PEPTIDES FOR INHIBITION OF ANGIOGENESISFeb 25, 15Feb 09, 17[A61K, C07K]
2016/0333,084 METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESISAug 03, 16Nov 17, 16[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9890216 Antibodies with engineered IgG Fc domainsAug 30, 13Feb 13, 18[A61K, C07K]
9850295 Vaccines and diagnostics for the ehrlichiosesFeb 23, 17Dec 26, 17[A61K, C07K]
9814768 English Title Not AvailableFeb 27, 17Nov 14, 17[A61K]
9803014 JAM-C antibodies and methods for treatment of cancerOct 24, 13Oct 31, 17[A61K, G01N, C07K]
9771426 Engineered immunoglobulin FC polypeptidesDec 31, 14Sep 26, 17[C07H, C12P, C12N, C07K]
9731033 Methods and compositions relating to improved lentiviral vectors and their applicationsSep 12, 16Aug 15, 17[A61K, C12N, C07K]
9701719 Attenuated Chikungunya virusSep 26, 13Jul 11, 17[A61K, C07K]
9693994 Class IIa HDAC inhibitors for the treatment of infectionApr 09, 15Jul 04, 17[A61K]
9650426 RTEF-1 variants and uses thereofJun 09, 14May 16, 17[A61K, C07K]
9645148 English Title Not AvailableAug 04, 15May 09, 17[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0375,102 UROCORTIN-III AND USES THEREOFAbandonedJul 08, 16Dec 29, 16[A61K]
2016/0243,142 AVICIN D FOR TREATMENT OF MANTLE CELL LYMPHOMAAbandonedFeb 22, 16Aug 25, 16[A61K]
2015/0299,306 METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESISAbandonedJul 07, 15Oct 22, 15[C07K]
2014/0288,418 APPARATUS AND METHODS FOR PATHLENGTH MULTIPLEXING FOR ANGLE RESOLVED OPTICAL COHERENCE TOMOGRAPHYAbandonedMar 17, 14Sep 25, 14[A61B]
2014/0235,482 IMMUNOGLOBULIN FC POLYPEPTIDESAbandonedFeb 14, 14Aug 21, 14[G01N]
2014/0179,624 CYTOPROTECTIVE DERIVATIVES OF AVICIN D AND METHODS OF MAKING AND USING THEREOFAbandonedDec 20, 13Jun 26, 14[C07H]
2013/0177,624 MIRNA EXPRESSION IN ALLERGIC DISEASEAbandonedMay 07, 10Jul 11, 13[A61K, C12Q, C12N]
2013/0177,978 IMMUNOREACTIVE EHRLICHIA P120/P140 EPITOPES AND USES THEREOFAbandonedDec 10, 12Jul 11, 13[C07K]
2012/0238,509 UROCORTIN 2 ANALOGS AND USES THEREOFAbandonedAug 27, 10Sep 20, 12[A61K, C12N, A61P, C07K, B32B]
2012/0141,469 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALINGAbandonedOct 19, 11Jun 07, 12[A61K, C12N, A61P]
2012/0114,636 LOW MOLECULAR WEIGHT CYCLIN E (LMW-E) AS A BIOMARKER FOR PERSONALIZATION OF CANCER THERAPIESAbandonedMar 10, 10May 10, 12[A61K, G01N, A61P]
2012/0088,287 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALINGAbandonedOct 19, 11Apr 12, 12[C12N]
2012/0014,993 CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURESAbandonedJun 17, 11Jan 19, 12[A61K, C12N, G01N, A61P, C40B]
2011/0287,088 MODULATION OF OLFML-3 MEDIATED ANGIOGENESISAbandonedNov 30, 09Nov 24, 11[A61K, C07H, A61P, C07K]
7985435 Triterpene compositions and methods for use thereofExpiredJan 15, 10Jul 26, 11[A61K, C07H, A61P]
2011/0117,008 USE OF AVICINS TO DELIVER THERAPEUTIC AND DIAGNOSTIC AGENTSAbandonedNov 24, 08May 19, 11[A61K, C07H, A61P]
2011/0052,677 MODULATION OF SRPX2-MEDIATED ANGIOGENESISAbandonedMar 03, 09Mar 03, 11[A61K, C07H, A61P, C07K]
2011/0053,803 METHODS FOR CREATING ANTIBODY LIBRARIESAbandonedAug 25, 10Mar 03, 11[C40B]
2010/0292,316 IMPROVED THERAPEUTIC METHODS AND COMPOSITIONS COMPRISING CHROMAN RING COMPOUNDSAbandonedJul 09, 08Nov 18, 10[A61K, A61P]
7754211 Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigensExpiredOct 13, 04Jul 13, 10[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.